Company profile
UK company 14690170, incorporated on 27 February 2023.
Home - GitLife Biotech
We will set the global standard in the management of provenance and integrity for biological assets; enabling the potential of synthetic biology to be realised worldwide.
Company number 14690170
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
CS01 | Transaction MzUzMjkzODk0M2FkaXF6a2N4
Published 15 Jul 2026 14:20
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
GitLife Biotech develops DNA-based biosecurity tools and a version control system for synthetic biology using DNA barcoding.
The company set the global standard in the management of provenance and integrity for biological assets, enabling the potential of synthetic biology to be realised worldwide. It accomplishes this by setting the international standard for version control and biological asset integrity while enabling collaboration between governmental, commercial, academic and NGO entities.
The company only started trading in 2023.
1 Feb 2024 to 31 Mar 2025
Synthetic biology (SynBio) is a young and exciting field that combines many different scientific disciplines to redesign organisms for useful purposes by engineering them to perform new functions. SynBio has potential to revolutionise many existing industries and resolve crises in agriculture, energy and healthcare. There is no surprise that substantial f...
1 Feb 2024 to 31 Jan 2025
In this exciting collaborative project, NCIMB, an established Scottish biotechnology company, is teaming up with GitLife Biotech (GLB), a spinout from Newcastle University. The partners aim to develop new innovative products and services using groundbreaking Engineering Biology protocols. The proposed project centres around the development of a new class ...
1 Nov 2023 to 30 Apr 2025
Synthetic Biology (SynBio) is the application of engineering principles to biology. Synthetic Biologists think of proteins as machines, composed of multiple different components, each encoded by genes or parts of genes. By rearranging genes, they can make proteins with new functions. SynBio also uses computer modelling heavily, mapping what genes should g...
